Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registry

Annals of Rheumatic Diseases, 05/17/2012

This nationwide observational study of rheumatoid arthritis (RA) patients documented significantly reduced radiographic progression during tumour necrosis factor α inhibitors (TNF–I) treatment compared with the previous period of disease–modifying antirheumatic drugs (DMARD) treatment.

Print Article Summary Cat 2 CME Report